We are pleased to announce that Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions from 5th to 8th September in Chicago, Illinois.

This event, hosted by the American Heart Association, brings together leading experts to discuss the latest research and advancements in hypertension.

The conference features oral and poster presentations, panel discussions, and sessions tailored for clinicians, researchers, and primary care providers.

To connect with Dr. Taubel during the event, please reach out to arrange a meeting.

Tofind out more, click here.

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event